Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by Walterthedogon Nov 06, 2020 12:24pm
101 Views
Post# 31851950

RE:Last post for me . Respect for other shareholders in agony.

RE:Last post for me . Respect for other shareholders in agony. It really is just too painful. I don't think we are dealing with a smart person here. No one is going to buy this stock when they know another tranche of financing is just going to tank the price any day. I'd say we are going to be in the sewer until this financing closes. Will we ever see any money start coming in instead of flowing out? Q2 was encouraging and we did have positive cash flow so we know its possible. Hard to say. By the time we start seeing any revenue come in from new products it will be summer of next year and by then, who knows what price we will be at. KISS was the big promise and my best guess is that we are currently selling about 200 000$ worth per quarter. Our share of dried sales is likely zilch on OCS due to cheaper alternatives but hopefully we will have enough sales with everything combined to keep the lights on until our 2.0 sales pick up steam. Maybe we see some good revenue increase by second half of 2021. Not sure there is anything here for an investor to invest in and management certainly raises enough red flags to keep anyone with a brain away. Small chance traders run this thing up when new products are launched but other than that we are in for a long painful wait with maybe no reward for patience at the end. But from my perspective, I can't sell at this level after all this time. The minute I do, we will go up for no reason. Peace out friends. My advice (which is absolutely worthless) is sell if you see a better opporrunity or prepare to wait another year or 2 for any movement
<< Previous
Bullboard Posts
Next >>